Revolution Medicines (RVMD) is up 14.2%, or $5.74 to $46.19.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on RVMD:
- Morning Movers: Kroger rises following second quarter results
- Revolution Medicines announces results from daraxonrasib Phase 1 trials
- Promising Position of Revolution Medicines’ Zoldonrasib Justifies Buy Rating
- Revolution Medicines price target raised to $70 from $67 at Wells Fargo
- Promising Potential of Daraxonrasib in Pancreatic Cancer Boosts Buy Rating for Revolution Medicines